Nocturia
Etiology, Pathology, Risk Factors, Treatment and Emerging Therapies
Published on 28. August 2019
Book
Paperback/Softback
154 pages
978-0-12-820097-1 (ISBN)
Description
Nocturia: Etiology, Pathology, Risk Factors, Treatment and Emerging Therapy includes the background, prevalence, etiology, risk factors, adverse effects and morbidity, as well as current and emerging treatments related to nocturia. Often considered a normal part of aging, nocturia can often be overlooked as a risk factor associated with serious outcomes such as mortality, morbidity, negative economic implications and decreased quality of life. This book provides comprehensive information on all aspects of nocturia as well as how the emerging therapies can provide safe, effective and low-cost treatment.
This is an important reference for researchers, urologists and clinicians interested in improving diagnosis and treatment of nocturia.
This is an important reference for researchers, urologists and clinicians interested in improving diagnosis and treatment of nocturia.
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 229 mm
Width: 152 mm
Weight
250 gr
ISBN-13
978-0-12-820097-1 (9780128200971)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
King C. Lee | Jeffrey P. Weiss MD
Nocturia
Etiology, Pathology, Risk Factors, Treatment and Emerging Therapies
E-Book
09/2019
Academic Press
€144.00
Available for download
Persons
Dr. King Lee, PhD is currently an adjunct professor at Quinnipiac University, teaching Advanced Pharmacology and related courses to doctoral students in nursing. Dr. King Lee has performed multiple research projects and clinical studies in pharmacology, including clinical studies investigating the characteristics and new drug treatment for nocturia in patients with severe nocturia (the topic of the current book). He has authored and co-authored over 55 peer-reviewed manuscripts (scientific and professional papers, and review articles) and over 45 scientific abstracts. He has also authored chapters of several books. He has been an invited speaker to multiple national and international professional conferences or scientific meetings. Dr. Jeffrey Weiss, MD, FACS is Professor & Chair in the Dept of Urology at SUNY Downstate College of Medicine. He is ACGME Program Director at SUNY Downstate Urology where he serves as head of the Academic Executive Committee. He is Chief of Urology at the VA New York Harbor Healthcare System. Dr. Weiss is the primary author of over 300 peer reviewed scientific articles, abstracts and book chapters as well as co-author of 4 urological textbooks. He is a member the International Continence Society, the Society for Urodynamics and Female Urology and the Society of University Urologists. Dr. Weiss has been Governor for the American College of Surgeons for the NYC area as well as District II representative board member to the NY Section of the American Urological Association. He is currently engaged in research regarding the cause and treatment of nocturia, overactive bladder and prostate cancer.
Content
1. Introduction and Background2. Etiology, Pathology and Risk Factors3. Epidemiology and Prevalence4. Adverse Effects and Co-Morbidity5. Diagnosis, Assessment and Examination6. Management and Treatments7. Emerging Novel Therapies8. Summary and Conclusion